Litcius/Paper detail

Nemolizumab: First Approval

Susan J. Keam

2022Drugs60 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePrurigo nodularisAtopic dermatitisDupilumabPrurigoDermatologyAnakinraImmunologyDiseaseInternal medicineDermatology and Skin DiseasesIL-33, ST2, and ILC PathwaysUrticaria and Related Conditions
Nemolizumab: First Approval | Litcius